Ampicillin Market Forecasts to 2028 – Global Analysis By Application (Respiratory Tract Infections, Urinary Tract Infections), End User (Research Laboratories, Pharmaceutical Companies), and By Geography
According to Stratistics MRC, the Global Ampicillin market is accounted for $168.62 million in 2020 and is expected to reach $241.63 million by 2028 growing at a CAGR of 4.6% during the forecast period. Some of the key factors propelling the market growth include rising geriatric population, new product innovations, increasing R&D investments by major players, rising prevalence of infectious diseases, regulatory concerns to control the antibiotic resistance problem, and increasing demand for effective antibiotic drugs especially in the emerging economies across Asia Pacific and Latin America. However, the emergence of drug resisting microorganisms is hindering the market growth.
Ampicillin, a semi-synthetic derivative of penicillin, causes cell death by interfering directly with bacterial cell wall synthesis and indirectly by initiating the release of enzymes that further aids in altering the cell wall. Presence of an amino group is the only difference between ampicillin and penicillin. An amino group in ampicillin aids penetration through the outer membrane of gram-positive and certain gram-negative bacteria. Ampicillin finds use as an antibiotic in preventing and treating a number of bacterial infections such as respiratory tract infections, meningitis, salmonella infections, urinary tract infections and endocarditis. It is also used in treatment of group B streptococcal infection in newborns. Ampicillin was the first 'broad spectrum' type of penicillin having activity against gram positive bacteria.
By type, the ampicillin capsules segment is projected to grow at the significant rate during the forecast period. Ampicillin capsule is available as a generic drug only. Ampicillin also comes as an oral suspension as well as in an intravenous form, which is only given by a healthcare provider. Ampicillin oral capsule is used to treat infections that are caused by certain types of bacteria. The administration of 500 mg dose of ampicillin capsules results in an average peak blood serum level of approximately 3.0 mcg/mL.
On the basis of geography, Asia Pacific region is expected to have considerable market growth during the forecast period, owing to increase in incidence and mortality rate of infectious diseases, including pneumonia, in emerging markets, such as India and China, is likely to drive the demand for ampicillin antibiotics in the next few years. Rise in the number of antibiotic manufacturers and favourable government support for raising awareness among people about infectious diseases in these countries are anticipated to boost the ampicillin market in Asia Pacific.
Some of the key players in Ampicillin Market include Jiangxi Dongfeng Pharmaceutical Co. Ltd., United Laboratories, Fresenius Kabi, ACS Dobfar Spa, DSM, Kopran, Shandong Lukang Pharmaceutical, Antibioticos, North China Pharmaceutical Group Corp., Huaxing Pharmaceutical, and CSPC Pharmaceutical.
Estimated Market Size in 2020:
USD 168.62 million
Compound Annual Growth Rate (CAGR) from 2020 to 2028:
Predicted 2028 Value:
USD 241.63 million
Tables, Graphs & Figures
Target Bacteria Type, Intake Method, Type, Sales Channel, Purity Type, Application, Vertical, End User and Region
Core Drivers and Opportunities:
Restraining Factors & Market Threats:
Target Bacteria Types Covered:
• Gram Negative Bacteria
• Gram Positive Bacteria
Intake Methods Covered:
• By Injection into a Muscle
• By Mouth
• Ampicillin Sodium
• Ampicillin Sodium for Injection
• Ampicillin Capsules
• Ampicillin Sodium and Sulbactam Sodium for Injection
• Ampicillin Tablets
• Ampicillin Sodium and Cloxacillin Sodium for Injection
• Ampicillin Granules
Sales Channels Covered:
• Direct Sales
Purity Types Covered:
• Purity 98%
• Purity 96%
• Salmonella Infections
• Respiratory Tract Infections
• Urinary Tract Infections
• Other Applications (Group 3 Streptococcal Infections)
End Users Covered:
• Research Laboratories
• Pharmaceutical Companies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Key Questions Answered In The Report
The Global Ampicillin Market is majorly driven by growing geriatric population, rising R&D investments by major players, and regulatory concerns to control the antibiotic resistance problem.
The ampicillin capsules segment is growing at a highest CAGR as it is used to treat infections that are caused by certain types of bacteria and the administration of 500 mg dose of ampicillin capsules results in an average peak blood serum level of approximately 3.0 mcg/mL.
North America dominated with a significant market share due to an increase in incidence of sexually transmitted diseases such as gonorrhea and syphilis in the U.S.
Asia Pacific market is growing at a highest CAGR owing to rise in the number of antibiotic manufacturers and increase in incidence and mortality rate of infectious diseases, including pneumonia, in emerging markets, such as India and China.
Key players in Ampicillin Market include Jiangxi Dongfeng Pharmaceutical Co. Ltd., United Laboratories, Fresenius Kabi, ACS Dobfar Spa, DSM, Kopran, Shandong Lukang Pharmaceutical, Antibioticos, North China Pharmaceutical Group Corp., Huaxing Pharmaceutical, and CSPC Pharmaceutical.
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.